Neoangiogenesis in cervical cancer: focus on CD34 assessment

Rom J Morphol Embryol. 2010;51(2):289-94.

Abstract

Despite recent advances in understanding the immune mechanisms of cervical cancer (CC), relapse remains still an actual issue and recognition of new predictive biomarkers is essential.

Aim: The purpose of this retrospective study was to investigate neo-angiogenesis in CC and its possible utility as prognostic biomarker.

Material and methods: Paraffin-embedded tissue samples from 61 consecutive women with CC were immunostained for CD34 and E-cadherin. Statistical analysis was performed in SPSS-12 software, p<0.05.

Results: Statistically significant differences between CD34 distribution among three interest tumor regions: micro-vessels density increase from central to peripheral area (chi(2), p<0.05); statistically significant correlation between CD34 expression, particularly in stromal and peripheral sites, E-cadherin (Spearman r1=-0.321) and lymphatic invasion (Spearman r2=0.455) (p<0.05) were reported. Overall five-year survival is clearly dependent on level and distribution of tumor angiogenesis among defined area of interest as suggested by Kaplan-Meier analysis.

Conclusions: Angiogenesis is essential for guiding CC evolution and prognosis, particularly in squamous invasive types.

MeSH terms

  • Antigens, CD34 / analysis*
  • Blood Vessels / metabolism
  • Blood Vessels / pathology*
  • Female
  • Humans
  • Immunohistochemistry
  • Neovascularization, Pathologic / metabolism
  • Neovascularization, Pathologic / pathology
  • Prognosis
  • Retrospective Studies
  • Uterine Cervical Neoplasms / blood supply*
  • Uterine Cervical Neoplasms / immunology
  • Uterine Cervical Neoplasms / pathology

Substances

  • Antigens, CD34